Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Most Influential 2018: Edwards Lifesciences CEO Mike Mussallem leads company making medical breakthroughs
#Management Changes #Expand
Nov 28, 2016
Edwards buys Israeli co Valtech Cardio for $1b
Dec 16, 2003
PVT medical technology firm sold to Edwards Lifesciences
Edwards Lifesciences is specializing in patient-focused medical innovations for structural heart disease and critical care monitoring. The company is dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
Edwards Lifesciences (Israel) Ltd operates as a subsidiary of Edwards Lifesciences Corporation. The Israeli R&D center was opened after the acquisition of Percutaneous Valve Technologies in 2003 and focuses on the development of percutaneous heart valves and other percutaneous techniques for heart valve repair and replacement.
The Edwards Israel Innovation Center (EIIC) focuses on developing early-stage cardiovascular technologies. Our passion, ingenuity, collaboration, and new ways of thinking enable us to develop devices and therapies that help patients around the world. Our commitment to a diverse and inclusive work culture welcomes all perspectives to help us thrive. We invite mission-driven employees in engineering, quality assurance, regulatory affairs, cyber security & data analytics and more to join us to impact patients' lives.